Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Clinical Trials
Impact of COVID-19 on Winning New Business
Wuxi Clinical’s Vice President of Biometrics, David Ng, talks about the impact of COVID-19 on clinical trials and business relationsOnline Exclusives Tim Wright, Editor, Contract Pharma 06.03.20
-
Clinical Trials | Drug Development | Trials & Filings
Octapharma Extends Funding for COVID-19 Study
Study evaluating using IVIG as investigational coronavirus treatment for adults experiencing respiratory failure.Contract Pharma Staff 06.03.20
-
Clinical Trials | Drug Development | Industry News | Trials & Filings
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.Contract Pharma Staff 06.03.20
-
Breaking News | Clinical Trials | Industry News | Information Technology
Almac Introduces Simplify
An advanced IRT solution enabling faster clinical trial start-upContract Pharma Staff 06.02.20
-
Breaking News | Clinical Trials | Industry News
LabCorp Launches New COVID-19 Clinical Trial Site
To connect patients with US research trials; streamlining recruitment into studies to speed researchContract Pharma Staff 06.01.20
-
Clinical Trials | Trials & Filings
Proteostasis Gets Positive Preclinical Results in COVID-19
PTI-129, a once-daily, oral small molecule demonstrates the potential to reduce viral protein production in host cells.Contract Pharma Staff 06.01.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
Daiichi Sankyo, Syneos Health Form Strategic ADC Alliance
Syneos to provide strategic and operational services for three lead Daiichi antibody drug conjugates.Contract Pharma Staff 06.01.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Labcorp Accelerates Adoption of Decentralized Clinical Trials
Expands technology ecosystem through alliance with MedableContract Pharma Staff 05.29.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Roche Initiates Phase III Trial in COVID-19 Pneumonia
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.Contract Pharma Staff 05.28.20
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Montefiore, Einstein Test New Drug Combo to Conquer COVID-19
Researchers hope giving remdesivir along with a powerful anti-inflammatory could be the key to treating the most severe COVID-19 casesContract Pharma Staff 05.26.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Logistics
The Importance of CAR-T Cell Therapy in Clinical Trials
The Industry’s Evolving, Maturing FocusPanteli Theocharous, Global Vice President, Cell and Gene Therapy Strategy Lead, PPD 05.26.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Glenmark Begins Phase III Trial of Anti-Viral Combo in COVID-19
To test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment.Contract Pharma Staff 05.26.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Chi-Med, BeiGene Enter Clinical Collaboration
Will evaluate combinations of surufatinib and fruquintinib with tislelizumab for multiple solid tumor cancer indicationsContract Pharma Staff 05.26.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationOnline Exclusives Kristin Brooks, Contract Pharma 05.18.20
-
Clinical Trials
Pioneering Medicine Forward
May 20th marks Clinical Trials Day, celebrating 273 years of clinical trialsOnline Exclusives Tina Bland, Senior Consultant, KCR Trial Execution Consulting 05.18.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Supply Chain
Yourway and Firma Ink Clinical Supply Deal
Collaborate to administer coordinated supply delivery for home-health clinical trial visitsContract Pharma Staff 05.12.20
-
Breaking News | Clinical Trials | Industry News
Tufts CSDD Releases New Study
Establishes demographic benchmarks for pivotal clinical trials, showing areas of under-representationContract Pharma Staff 05.12.20
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Catalent Provides Clinical Support for COVID-19 Study
Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patientsContract Pharma Staff 05.08.20
-
Bio News | Breaking News | Clinical Trials | Industry News
Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution
Designed to evaluate clinical trial protocol and charter to determine if novel COVID endpoint adjudication pathways should be addedContract Pharma Staff 05.08.20
